LIPO: lipella.com Company Cash Funds

Official company branding of Lipella Pharma (LIPO)

Changes in cash asset volume demonstrate the efforts of Lipella Pharmaceuticals (LIPO) to develop patent-protected local cystitis treatment systems within a niche segment. The company is implementing advanced drug delivery methods to the bladder to reduce therapy toxicity. However, a revenue shortfall coupled with high R&D expenditures is depleting reserves, and the 0.00 metric indicates the current liquidity status of the business.

LIPO - Lipella Pharma Company Cash Volume over the range 04/28/2023 - 07/19/2025

Lipella Pharmaceuticals, Inc. - analytical breakdowns and key metrics (LIPO)

- stock value and consensus price forecast:
- market capitalization information:
Fundamental valuation:Lipella Pharma
Signature product of lipella.com

Laboratory automation at Lipella Pharmaceuticals (LIPO) accelerates drug development by optimizing personnel costs. This indicator measures the total volume of liquid assets, creating an objective safety cushion for the business. Rising liquidity amid declining capitalization signals fundamental undervaluation or hidden risks to the market. Analysts utilize this metric to assess the issuer's financial stability. By evaluating the cash reserve trend, an investor determines the real value of the company's assets.

Analysis of competing companies

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|Company Liquid Assets Pacira BioSciences (PCRX)|ARS Corp - Company Cash Volume|TBPH: Company Cash Funds|AQST: Company Cash Volume|SCPH - Company Liquid Assets|TECX (Tectonic) - Company Cash Volume|Company Cash Reserve Tonix Pharmaceuticals Holding Corp. TNXP|Company Cash Funds SXT Pharmaceuticals (SXTC)|Company Cash Volume Eupraxia Pharmaceuticals Inc. (EPRX)|Company Cash Funds BioHarvest Sciences BHST|EXOZ (Invizyne) - Company Total Cash Volume|ORMP: Company Cash on Hand|ENTX (Entera Bio Ltd) - Company Cash and Cash Equivalents|HYFT: Company Cash Volume|Company Cash on Hand ABVC BioPharma Inc.|CPIX (cumberlandpharma.com) - Company Cash Volume|Company Cash Funds QNTM|Company Cash Volume FGEN|Company Cash on Hand Telomir Pharmaceuticals TELO|Company Cash Volume RANI (ranitherapeutics.com)|SNYR (Synergy CHC Corporation) - Company Total Cash Volume|RLYB - Company Cash Funds|LEXX (Lexaria Bioscience Corp.) - Company Cash and Cash Equivalents|pulmatrix.com (PULM) - Company Cash Funds|PTHL (Pheton) - Company Cash Funds|Company Cash Funds Aptorum|Company Cash Reserve Lyra Therapeutics Inc. LYRA|Company Cash Volume IBO|TNFA (TNF Pharmaceuticals, Inc.) - Company Cash Balance|Company Cash Funds cbdMD, Inc. YCBD|Company Cash Balance PRFX|Altamira Therapeutics Ltd. - Company Cash Volume|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance